Overall Technical outlook

Price Summary

On 2025-09-03, Aurobindo Pharma Limited's stock started at 1025.0, soared to 1041.5, dropped to 1021.0, and finished the day 0.97% higher at 1034.9, with a trading volume of 982433 shares.
Throughout the 52-week period, the stock hit a high of 1567.25 and a low of 1022.2.
Future price predictions suggest a range between 730.0 and 1930.0, with an average expected price of 1293.3928, as per 28 analysts.

Technicals


Aroon: The current state of the AROON is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
AUROPHARMA aroon 570764
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for AUROPHARMA, with no strong trend emerging.
AUROPHARMA bbands 570764
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR remains in a bearish mode, setting a resistance level that could impede any upward movement. This resistance indicates that the market may continue to face bearish pressure, with limited potential for breaking higher.
AUROPHARMA psar 570764
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The K-line has crossed above the D-line on the stochastic indicator, while remaining below 20, indicating a possible bullish move. This pattern is often viewed as a signal that the market might start to rise from a low point, potentially leading to gains. Investors might see this as a favorable entry opportunity.
AUROPHARMA stoch 570764
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The 20-50-100 period moving averages are positioned for a bullish trend, but the slopes of the faster averages hint at a possible trend reversal. While the overall outlook remains positive, the weakening momentum in the shorter-term averages suggests that the current trend might not hold for long.
AUROPHARMA trippleSMA 570764
Tripple SMA chart for Aurobindo Pharma Limited


In order to draw meaningful inferences from a company's technical data, it is essential to first consider its fundamentals. This includes reviewing financial metrics like revenue, profit margins, and debt-to-equity ratios. Additionally, understanding the broader industry landscape, including market trends and competitive pressures, is crucial. By integrating these insights with the company's technical performance, such as stock price fluctuations and trading volume, one can make more informed investment decisions.